Glycyrrhetenic acid has been shown to inhibit the expression of IL-17A and IFN-γ, and its capacity to suppress cell proliferation and reverse inflammatory markers suggests it may alleviate psoriasis by modulating the immune response and keratinocyte proliferation through the IL-17A/SIRT1/STAT3 signaling axis [10]. Here, IL17A is linked to psoriasis.